A government-appointed committee makes a recommendation that would save taxpayers $260 million within a year, but it’s ignored. And people at risk of heart attacks lose out. Let me explain via a ripping…
Articles on PBS
Displaying 81 - 95 of 95 articles
The body responsible for regulating drugs in Australia, the Therapeutic Goods Administration (TGA), is poised to decide whether to restrict access to benzodiazepines, such as Xanax, Valium and Normison…
The retail pharmacy industry in Australia has successfully acquired a monopoly on supplying medicines paid for by the government or consumers. The industry describes this set-up as being the “best subsidized…
The Commonwealth could save A$1.3 billion each year by reforming the Pharmaceutical Benefits Scheme (PBS), according to a report released today by the Grattan Institute. The report, Australia’s bad drug…
The Australian government introduced a controversial delay to the approval process for subsidised medicines last year, in an attempt to cut costs. We decided to examine the timelines of the approval process…
A growing number of people globally live with chronic illness. By the time they reach 65, most Australians have at least one chronic condition and 80% have three or more. Pharmaceutical treatment is often…
The Trans-Pacific Partnership Agreement (TPPA) could interfere with Australia’s anti-smoking and medicine prices legislation…
The Administrative Appeals Tribunal has granted pharmaceutical company Aspen Pharmacare a legal stay against the Therapeutic Goods Administration’s (TGA) ban on some of its products. The company took the…
Recent reductions to generic drug prices should go deeper as more generic alternatives become available with the expiration…
Boys are likely be offered subsidised vaccinations against the sexually transmitted, wart and cancer-causing human papillomavirus (HPV) following a government committee recommendation to expand the use…
Boehringer Ingelheim, manufacturer of the expensive anti-clotting drug dabigatran, has initiated a lobbying campaign to get it listed on the Pharmaceutical Benefits Scheme (PBS). The company’s efforts…
Any parent who watches kids’ weekend footy knows that if the ref misses a breach of the rules, merry hell breaks loose. But referees are human and sometimes make errors. We forgive the odd one pretty quickly…
In an attempt to contain growing health costs, the Australian Government has resisted recommendations to subsidise the pain medication Targin on the Pharmaceutical Benefits Schedule. Not only is this a…
The fanfare around Health Minister Nicola Roxon’s announcement yesterday that the government would fund 13 new medicines on the PBS is a reminder of the power and influence involved in the selection and…
Federal and state governments in Australia appear much less successful than their United States counterparts in recovering taxpayers funds lost to suspected large-scale corporate fraud. For instance, there…
Top contributors
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor of Health Economics, The University of Melbourne
-
ARC Future Fellow, Australian National University
-
Professor of Health Economics, Flinders University
-
Professor of Health Economics, University of Technology Sydney
-
Professor of Trade Law and Taxation, Queensland University of Technology
-
Professor of Health Economics, The University of Melbourne
-
Professor of Journalism, Media and Communication, Queensland University of Technology
-
Dean, University of Wollongong
-
Professor of Public Health, La Trobe University
-
Senior Research Fellow, University of Technology Sydney
-
Research Fellow, Flinders University
-
Associate Professor of Media Studies, University of Colorado Boulder
-
Professor of Health Economics, Deputy Director of CHERE, University of Technology Sydney